Do People With Nerve Pain Use Cannabis Differently Than Those With Other Pain?

Cross-sectional survey of 104 adults (61.5% female) receiving care at a pain clinic. Pain categorized as neuropathic or non-neuropathic using ID-Pain scores. Cannabis product use assessed by frequency and duration. Linear regression models adjusted for age and sex.

If neuropathic pain specifically drives more intensive cannabis use, that has implications for both medical cannabis programs and pain clinic practice. It suggests cannabis may be filling a gap where conventional pain treatments fall short—and that research on cannabis for nerve pain specifically should be prioritized over general chronic pain research.

This pattern-of-use data complements clinical trial evidence. RTHC-00158 showed that THC:CBD improved pain scores specifically in cancer patients (even without improving overall symptoms), and RTHC-00161 found that medical marijuana access reduced strong opioid prescriptions after cancer surgery. Together, these studies suggest cannabis may have a particular niche in pain management—not as a general analgesic, but as a targeted option for pain types that respond poorly to other treatments.

Small sample from a single pain clinic. Cross-sectional design can't determine causation—people with neuropathic pain may use more cannabis because it works, because they're more desperate, or for other reasons. Self-reported cannabis use. The ID-Pain tool classifies pain type based on symptoms rather than confirmed diagnoses. No data on whether the cannabis actually helped with pain.